Company Reports 65% Quarterly Revenue Growth
SOMERSET, NJ-(Marketwired - Mar 31, 2017) -
Fourth Quarter 2016 Financial Results:
- Revenue of $8.8 million for fourth quarter 2016, 65% growth
over fourth quarter 2015
- GAAP net loss of $4.0 million, or $0.42 per share
- Non-GAAP adjusted net income of ($1.3 million), or ($0.12) per
share for the quarter
- Adjusted EBITDA of ($814,000) or (9.2%) of revenue for the
quarter
Full Year 2016 Financial Results:
- Revenue of $24.5 million for the year, 6% growth over 2015
- GAAP net loss of $8.8 million, or $0.95 per share
- Non-GAAP adjusted net income of ($2.0 million) or ($0.19) per
share for the year
- Adjusted EBITDA of ($605,000) or (2.5%) of revenue for the
year
Medical Transcription Billing, Corp. (NASDAQ: MTBC) (NASDAQ:
MTBCP), a leading provider of proprietary, cloud-based electronic
health records, practice management and mHealth solutions, today
announces financial and operational results for fiscal year 2016
and fourth quarter 2016 and provides a review of its most recent
and largest acquisition to-date. We will conduct a conference call
later today, Friday, March 31, 2017, at 8:30 a.m. Eastern Time to
discuss these results and management's outlook for future financial
and operational performance.
"We are pleased to announce 65% revenue growth over the fourth
quarter of 2015 as well as 65% growth over the third quarter of
2016, and our third consecutive quarter of quarter-over-quarter
revenue growth," says Mahmud Haq, MTBC's Chairman and CEO. He
continued, "We are greatly encouraged by the growth opportunities
provided by our recent acquisition and look forward to delivering
strong revenue and EBITDA growth in 2017."
As previously announced, on October 3, 2016 MTBC achieved a
corporate milestone in its acquisition of substantially all of the
assets of MediGain, LLC, a Texas-based medical billing company, and
its subsidiary, Millennium Practice Management, LLC, a New
Jersey-based medical billing company (together, "MediGain").
Expected to be accretive to shareholders in 2017, the acquisition
reflects the strategic nature of MTBC's acquisition-based growth
strategy.
Fourth quarter 2016 financial results
Revenues for three months ended December 31, 2016 were $8.8
million, compared to $5.4 million in the same period last year,
which represents 65% revenue growth over the fourth quarter of
2015. The increase was primarily a result of the MediGain
acquisition, which occurred on October 3, 2016.
The fourth quarter 2016 GAAP net loss was $4.0 million, or 46%
of net revenue, compared to a GAAP net loss of $802,000 for the
same period last year. The increase in the net loss is primarily
the result of planned, short-term increases in operating expenses
related to the acquisition and integration of MediGain. According
to Bill Korn, Chief Financial Officer, "Fourth quarter revenue
increased by $3.5 million or 65%, while direct operating costs
increased from $2.4 million in the fourth quarter 2015 to $6.1
million in the fourth quarter 2016, and general and administrative
expenses increased from $2.6 million to $4.3 million."
"On October 3, 2016, the day we purchased MediGain, we began
reducing expenses. For example, MediGain's four subcontractor firms
represented $750,000 of the fourth quarter 2016 direct operating
expense, and as of today, we have transitioned all work from these
subcontractor firms to our employees. These transitions
significantly reduced our operating expense, while improving
performance. We have also been deploying our experienced team and
technology to reduce personnel and related operating expense.
Finally, we have reduced the facilities costs associated with
MediGain by approximately 70%."
The GAAP net loss for fourth quarter was $0.42 per share,
calculated using the net loss attributable to common shareholders
divided by the weighted average number of common shares
outstanding.
Non-GAAP adjusted net income of fourth quarter was ($1.3
million), or ($0.12) per share, compared to the non-GAAP adjusted
net income of $121,000 in the same period last year. Non-GAAP
adjusted net income per share is calculated using the end-of-period
common shares outstanding, including shares which are part of
contingent consideration.
Adjusted EBITDA for the fourth quarter was ($814,000) or (9.2%)
of revenue, compared to adjusted EBITDA of $312,000, or 5.8% of
revenue, in the same period last year.
Full year 2016 financial results
MTBC's revenues for the year ended December 31, 2016 were $24.5
million, compared to $23.1 million last year, an increase of
6%.
GAAP net loss for the year ended December 31, 2016 was $8.8
million, 36% of net revenue, or $0.95 per share, compared to a GAAP
net loss of $4.7 million last year. The net loss for 2016 includes
$5.1 million of non-cash depreciation and amortization expense,
primarily the result of amortizing purchased intangible assets.
The increase in the net loss is primarily the result of an
increase in operating expenses due to the acquisition of MediGain
during the fourth quarter of 2016.
Non-GAAP adjusted net income for the year ended December 31,
2016 was ($2.0 million), or ($0.19) per share, compared to the
non-GAAP adjusted net income of ($1.4 million) last year.
Adjusted EBITDA for the year ended December 31, 2016 was
($605,000), or (2.5%) of revenue, compared to adjusted EBITDA of
($675,000), or (2.9%) of revenue, last year.
"The difference of $8.2 million between adjusted EBITDA and the
GAAP net loss in the year 2016 reflects $5.1 million of non-cash
amortization and depreciation expense, $1.9 million of stock-based
compensation, $1.0 million of integration and transaction costs
related to recent acquisitions, $197,000 of provision for taxes,
and $646,000 of net interest expense, offset by a $716,000 decrease
in the contingent consideration liability," says Bill Korn.
Management believes that our non-GAAP metrics are closer to
reflecting our cash flow, and we will focus on driving positive
adjusted EBITDA during 2017.
2017 Full Year Guidance
MTBC is providing the following forward-looking guidance for the
fiscal year ending December 31, 2017:
For the Fiscal Year Ending December 31, 2017 Forward-Looking
Guidance
|
Revenue
|
$30 - $31 million
|
Adjusted EBITDA
|
$2.0 - $2.5 million
|
The company anticipates full year 2017 revenue of approximately
$30 to $31 million, which represents growth of 22% to 27% over 2016
revenue. We expect adjusted EBITDA to be $2.0 to $2.5 million for
full year 2017, anticipating that the first quarter will be
slightly negative due to planned integration expenses, but each
successive quarter will be positive and reflect growth.
Cash Balance and Liquidity
As of December 31, 2016, the Company had $3.5 million in cash
and a working capital deficiency of approximately $7.4 million. At
year end, the Company's stockholders' equity was approximately $7.1
million and its accumulated deficit was approximately $17.9
million. In order to satisfy its existing obligations, the Company
believes additional funding will be necessary, which might be in
the form of sales of additional shares of its Series A Preferred
Stock, its common stock, or some other instrument. The Company may
in the future seek additional capital from public or private
offerings of its capital stock or it may elect to borrow additional
amounts under new credit lines or from other sources. If the
Company issues equity or debt securities to raise additional funds,
its existing stockholders may experience dilution, it may incur
significant financing costs, and the new equity or debt securities
may have rights, preferences and privileges senior to those of its
existing stockholders.
Management concluded that without additional financing, there
was substantial doubt about the Company's ability to continue as a
going concern within twelve months after the date the financial
statements were issued. The audit report included in the Company's
Annual Report on Form 10-K will contain a going concern
emphasis-of-matter paragraph.
Conference Call Information
MTBC management will host a conference call at 8:30 a.m. EDT on
Friday, March 31, 2017, to discuss the annual results of 2016. The
conference call will be accessible by dialing 844-802-2438, or
412-317-5131 for international callers, and referencing "MTBC
Fourth Quarter 2016 Earnings Call." An audio webcast of the call
will be available live and archived on MTBC's investor relations
website at ir.mtbc.com.
A replay of the conference call will be available approximately
one hour after conclusion of the call and will be accessible
through June 30, 2017. The replay can be accessed by dialing
877-344-7529, or 412-317-0088 for international callers, and
providing access code 10103771.
About MTBC
MTBC is a healthcare information technology company that
provides a fully integrated suite of proprietary web-based
solutions, together with related business services, to healthcare
providers practicing in ambulatory care settings. Our integrated
Software-as-a-Service (or SaaS) platform helps our customers
increase revenues, streamline workflows and make better business
and clinical decisions, while reducing administrative burdens and
operating costs. MTBC's common stock trades on the NASDAQ Capital
Market under the ticker symbol "MTBC," and its Series A Preferred
Stock trades on the NASDAQ Capital Market under the ticker symbol
"MTBCP."
For additional information, please visit our website at
www.mtbc.com.
Follow MTBC on Twitter, LinkedIn and Facebook.
Use of Non-GAAP Financial Measures
In our earnings releases, prepared remarks, conference calls,
slide presentations, and webcasts, we may use or discuss non-GAAP
financial measures, as defined by SEC Regulation G. The GAAP
financial measure most directly comparable to each non-GAAP
financial measure used or discussed, and a reconciliation of the
differences between each non-GAAP financial measure and the
comparable GAAP financial measure, are included in this press
release after the condensed consolidated financial statements. Our
earnings press releases containing such non-GAAP reconciliations
can be found in the Investor Relations section of our web site at
ir.mtbc.com.
Forward-Looking Statements
This press release contains various forward-looking statements
within the meaning of the federal securities laws. These statements
relate to anticipated future events, future results of operations
or future financial performance. In some cases, you can identify
forward-looking statements by terminology such as "may," "might,"
"will," "should," "intends," "expects," "plans," "goals,"
"projects," "anticipates," "believes," "estimates," "predicts,"
"potential," or "continue" or the negative of these terms or other
comparable terminology.
Our operations involve risks and uncertainties, many of which
are outside our control, and any one of which, or a combination of
which, could materially affect our results of operations and
whether the forward-looking statements ultimately prove to be
correct. Forward-looking statements in this press release include,
without limitation, statements reflecting management's expectations
for future financial performance and operating expenditures,
expected growth, profitability and business outlook, increased
sales and marketing expenses, and the expected results from the
integration of our acquisitions.
These forward-looking statements are only predictions, are
uncertain and involve substantial known and unknown risks,
uncertainties and other factors which may cause our (or our
industry's) actual results, levels of activity or performance to be
materially different from any future results, levels of activity or
performance expressed or implied by these forward-looking
statements. New risks and uncertainties emerge from time to time,
and it is not possible for us to predict all of the risks and
uncertainties that could have an impact on the forward-looking
statements, including without limitation, risks and uncertainties
relating to: the Company's ability to manage growth; integrate
acquisitions; effectively migrate and keep newly acquired customers
and other important risks and uncertainties referenced and
discussed under the heading titled "Risk Factors" in the Company's
filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of
this press release, even if subsequently made available by the
Company on its website or otherwise. The Company does not assume
any obligations to update the forward-looking statements provided
to reflect events that occur or circumstances that exist after the
date on which they were made.
MEDICAL TRANSCRIPTION BILLING, CORP.
|
CONSOLIDATED BALANCE SHEETS
|
AS OF DECEMBER 31, 2016 AND 2015
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
3,476,880
|
|
|
$
|
8,039,562
|
|
|
Accounts receivable - net of allowance for doubtful accounts of
$156,000 and $250,000 at December 31, 2016 and December 31, 2015,
respectively
|
|
|
4,330,901
|
|
|
|
2,211,979
|
|
|
Current assets - related party
|
|
|
13,200
|
|
|
|
13,200
|
|
|
Prepaid expenses and other current assets
|
|
|
618,501
|
|
|
|
621,492
|
|
|
|
Total current assets
|
|
|
8,439,482
|
|
|
|
10,886,233
|
|
Property and equipment - net
|
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jan 2025 to Feb 2025
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Feb 2024 to Feb 2025